297 related articles for article (PubMed ID: 38680679)
1. Engineering pluripotent stem cells with synthetic biology for regenerative medicine.
Mao Y; Wang S; Yu J; Li W
Med Rev (2021); 2024 Apr; 4(2):90-109. PubMed ID: 38680679
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of pluripotent stem cells and their derivatives: current status and future perspectives.
Pendse S; Vaidya A; Kale V
Regen Med; 2022 Sep; 17(9):677-690. PubMed ID: 35703035
[TBL] [Abstract][Full Text] [Related]
3. Synthetic developmental biology: build and control multicellular systems.
Ebrahimkhani MR; Ebisuya M
Curr Opin Chem Biol; 2019 Oct; 52():9-15. PubMed ID: 31102790
[TBL] [Abstract][Full Text] [Related]
4. Biomaterial Engineering for Controlling Pluripotent Stem Cell Fate.
Bertucci TB; Dai G
Stem Cells Int; 2018; 2018():9068203. PubMed ID: 30627175
[TBL] [Abstract][Full Text] [Related]
5. Challenges for the Applications of Human Pluripotent Stem Cell-Derived Liver Organoids.
Chang M; Bogacheva MS; Lou YR
Front Cell Dev Biol; 2021; 9():748576. PubMed ID: 34660606
[TBL] [Abstract][Full Text] [Related]
6. Human and Pig Pluripotent Stem Cells: From Cellular Products to Organogenesis and Beyond.
Xuan Y; Petersen B; Liu P
Cells; 2023 Aug; 12(16):. PubMed ID: 37626885
[TBL] [Abstract][Full Text] [Related]
7. Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy - The Turning Point of Cell-Based Regenerative Medicine.
Parsons XH
Br Biotechnol J; 2013 Oct; 3(4):424-457. PubMed ID: 24926434
[TBL] [Abstract][Full Text] [Related]
8. Modeling human liver organ development and diseases with pluripotent stem cell-derived organoids.
Ouchi R; Koike H
Front Cell Dev Biol; 2023; 11():1133534. PubMed ID: 36875751
[TBL] [Abstract][Full Text] [Related]
9. Synthetic biology for improving cell fate decisions and tissue engineering outcomes.
Vogel AM; Persson KM; Seamons TR; Deans TL
Emerg Top Life Sci; 2019 Nov; 3(5):631-643. PubMed ID: 33523179
[TBL] [Abstract][Full Text] [Related]
10. Updated perspectives on vascular cell specification and pluripotent stem cell-derived vascular organoids for studying vasculopathies.
Liu C; Niu K; Xiao Q
Cardiovasc Res; 2022 Jan; 118(1):97-114. PubMed ID: 33135070
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of pluripotent stem cells for regenerative medicine.
Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
[TBL] [Abstract][Full Text] [Related]
12. Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine.
Lee H; Son MY
Int J Stem Cells; 2021 Feb; 14(1):9-20. PubMed ID: 33632980
[TBL] [Abstract][Full Text] [Related]
13. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
14. A synthetic biology approach to engineering circuits in immune cells.
Hoces D; Miguens Blanco J; Hernández-López RA
Immunol Rev; 2023 Nov; 320(1):120-137. PubMed ID: 37464881
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human multipotent and pluripotent stem cells using surface nanotopographies and surface-immobilised bioactive signals: A review.
Wang PY; Thissen H; Kingshott P
Acta Biomater; 2016 Nov; 45():31-59. PubMed ID: 27596488
[TBL] [Abstract][Full Text] [Related]
16. Neural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrix.
Li Y; Liu M; Yan Y; Yang ST
World J Stem Cells; 2014 Jan; 6(1):11-23. PubMed ID: 24567784
[TBL] [Abstract][Full Text] [Related]
17. Emerging Methods for Enhancing Pluripotent Stem Cell Expansion.
Chan SW; Rizwan M; Yim EKF
Front Cell Dev Biol; 2020; 8():70. PubMed ID: 32117992
[TBL] [Abstract][Full Text] [Related]
18. Programming Morphogenesis through Systems and Synthetic Biology.
Velazquez JJ; Su E; Cahan P; Ebrahimkhani MR
Trends Biotechnol; 2018 Apr; 36(4):415-429. PubMed ID: 29229492
[TBL] [Abstract][Full Text] [Related]
19. Engineering the human pluripotent stem cell microenvironment to direct cell fate.
Hazeltine LB; Selekman JA; Palecek SP
Biotechnol Adv; 2013 Nov; 31(7):1002-19. PubMed ID: 23510904
[TBL] [Abstract][Full Text] [Related]
20. Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine.
Marchini A; Gelain F
Crit Rev Biotechnol; 2022 May; 42(3):468-486. PubMed ID: 34187261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
